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Abstract In mammals, the carboxy-terminal domain (CTD) of RNA polymerase (Pol) II consists  
of 52 conserved heptapeptide repeats containing the consensus sequence Tyr1-Ser2-Pro3-Thr4-
Ser5-Pro6-Ser7. Post-translational modifications of the CTD coordinate the transcription cycle and 
various steps of mRNA maturation. Here we describe Tyr1 phosphorylation (Tyr1P) as a hallmark of 
promoter (5′ associated) Pol II in mammalian cells, in contrast to what was described in yeast.  
Tyr1P is predominantly found in antisense orientation at promoters but is also specifically  
enriched at active enhancers. Mutation of Tyr1 to phenylalanine (Y1F) prevents the formation of the 
hyper-phosphorylated Pol IIO form, induces degradation of Pol II to the truncated Pol IIB form, and 
results in a lethal phenotype. Our results suggest that Tyr1P has evolved specialized and essential 




The activity of RNA Polymerase (Pol) II is responsible for transcription of mRNAs and many non-
coding RNAs. Essential for Pol II function is the carboxy-terminal domain (CTD) of its largest sub-
unit Rpb1 that consists of a highly conserved YSPTSPS heptad repetition (Buratowski, 2009; 
Heidemann et al., 2012). Post-translational modifications (PTMs) of the CTD coordinate both tran-
scription cycle transitions and loading of RNA processing complexes. In the recent years, novel 
PTMs were described in addition to the well-known Ser5P and Ser2P associated with early tran-
scription and elongation, respectively. These include Ser7P, involved in snRNA gene transcription 
(Chapman et al., 2007; Egloff et al., 2007), Thr4P associated to transcription elongation in mam-
mals (Hintermair et al., 2012) and to histone gene transcription in chicken (Hsin et al., 2011), and 
Tyr1P that in yeast is found at gene body locations, consistent with a role in transcription elonga-
tion (Mayer et al., 2012). This latter modification remains however so far uncharacterized in mam-






†These authors contributed 
equally to this work
Competing interests: The 
authors declare that no 
competing interests exist.
Funding: See page 16
Received: 17 December 2013
Accepted: 08 May 2014
Published: 09 May 2014
Reviewing editor: Danny 
Reinberg, Howard Hughes 
Medical Institute, New York 
University School of Medicine, 
United States
 Copyright Descostes et al. 
This article is distributed under 
the terms of the Creative 
Commons Attribution License, 
which permits unrestricted use 
and redistribution provided that 
the original author and source 
are credited.
SHORT REPORT
Genes and chromosomes | Genomics and evolutionary biology
Descostes et al. eLife 2014;3:e02105. DOI: 10.7554/eLife.02105 2 of 19
Short report
Results and discussion
To analyze expression and pattern of Tyr1P modified Pol II, we took advantage of our previously devel-
oped Tyr1P specific antibodies (3D12) (Mayer et al., 2012). We investigated various mouse and human 
cells and could detect Tyr1P in western blots for all examined lines, in most cases associated with the 
hyper-phosphorylated IIO form of Pol II (Figure 1—figure supplement 1). To address the function of 
Tyr1P, we next generated Raji cell lines expressing Pol II resistant to α-amanitin (Chapman et al., 2004) 
and carrying either wild-type (WT) or a mutant Rpb1 gene with substitution of tyrosine to phenylalanine 
(Y1F) in CTD repeats 4 to 51 (Figure 1—figure supplement 2). After expression of the mutant, we 
observed that Y1F yielded a truncated Rpb1 (Pol IIB, Figure 1A) and was unable to form the hyper-
phosphorylated IIO Pol II. After disruption of the activity of endogenous Pol II by α-amanitin (Figure 1B) 
and soon after disappearance of WT Rpb1, cells became rapidly inviable. This phenotype reveals an 
essential function of the Y1 residue that appears more drastic than T4A or S7A mutations, but compa-
rable with that of S5A (Chapman et al., 2007; Hintermair et al., 2012). We conclude that Tyr1P very 
likely contributes to stabilization of CTD and may occur early within the transcription cycle.
To gain further insight into the involvement of Tyr1P in the transcription cycle, we performed 
co-immunoprecipitation experiments in human cells using antibodies directed against various CTD 
modifications reflecting 5′ transcriptionally engaged (Ser5P, Ser7P) or elongating forms (Ser2P, Thr4P) 
of Pol II (Chapman et al., 2007; Hintermair et al., 2012; Mayer et al., 2012). Our experiments 
indicated clearly that Tyr1P co-immunoprecipitated with Ser5P and Ser7P but not Ser2P or Thr4P 
(Figure 2A). Consistently, signals for Tyr1P were observed in Ser5P and Ser7P but not in Ser2P 
co-immunoprecipitations. Thus, overall, this data points out an association of Tyr1P with early 
transcribing isoforms of human Pol II.
eLife digest When a gene is expressed, the DNA is first transcribed to produce an intermediate 
molecule called a messenger RNA (mRNA), which is then translated to produce a protein. RNA 
Polymerase II is an enzyme that makes mRNA molecules in organisms as diverse as plants, animals, 
and yeast.
RNA Polymerase II is a complex made of a number of proteins. The largest protein in this complex 
includes a ‘carboxy-terminal domain’ that has multiple repeats of seven amino acids one after the 
other. The first amino acid in each repeat, a tyrosine, is referred to as tyrosine-1. Adding various 
chemical tags to the amino acids in these repeats co-ordinates the steps involved in the transcription 
of genes. In yeast, for example, adding a phosphate group to tyrosine-1 seems to help the 
polymerase to proceed to make long mRNA molecules. However, it is not known what these 
chemical tags do in humans or other animals.
Now Descostes, Heidemann et al. (and independently Hsin et al.) have shown that the same 
phosphate groups on tyrosine-1 perform functions in vertebrates (animals with backbones) that are 
different to those performed in yeast. These functions include protecting the carboxy-terminal 
domain from being broken down inside cells, and transcribing the DNA that is upstream of genes.
Descostes, Heidemann et al. found that in human cells, RNA Polymerase II with phosphate 
groups on tyrosine-1 tends to bind to the beginning of genes. However, rather than moving along 
each gene and transcribing it, the polymerase then moves in the opposite (or ‘antisense’) direction 
to transcribe the DNA that is upstream of the gene. In most cases, however, the transcription of 
these ‘upstream antisense RNAs’ does not make a functional RNA molecule and transcription is 
paused. Furthermore, Descostes, Heidemann et al. found that when RNA Polymerase II that is not 
tagged with these phosphate groups is degraded in human cells, these cells rapidly die.
Descostes, Heidemann et al. also found that RNA Polymerase II with phosphate tags on tyrosine-1 
also binds to, and transcribes, sections of DNA called ‘enhancers’, which are outside of the genes but 
that help to activate nearby genes. Importantly, these transcribed enhancers are those that work to 
define the type of cell and tissue—for example a white blood cell—that any given cell will become.
Future studies should help to answer remaining questions such as: how do these chemical tags 
affect the transcription of genes that are specific to certain tissue types? And do these tags on RNA 
Polymerase II help to direct cells to become specific cell types?
DOI: 10.7554/eLife.02105.002
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To assess its relation to transcription genome-wide, we next performed Tyr1P ChIP-seq, using 
3D12 mAb, and compared it to Pol II and the other phospho-isoforms. We isolated significantly 
associated regions based on the signal distribution of the background-subtracted data (Figure 2—
figure supplement 1B) and found that Pol II and all isoforms, including Tyr1P, correlated with 
transcription levels of genes (Figure 2—figure supplement 2). At many gene locations, a predomi-
nant signal of Tyr1P at promoters was observed (Figure 2B, Figure 2—figure supplement 3). We 
further confirmed this by genome-wide profiling of Pol II isoforms at coding-gene locations (Figure 2C, 
Figure 2—figure supplement 4, Figure 2—figure supplement 5A for Ser2P profile). Our profiling 
analysis shows that Tyr1P signal is predominantly found at promoters similarly to Ser5P, weak or essen-
tially absent at gene bodies and weak at 3′ends in contrast to Ser2P elongating mark and Ser7P (asso-
ciated to both promoters and gene bodies). These observations are further supported by quantification 
of signals at various genic sections (Figure 2—figure supplement 6) and reinforce our conclusion that 
human Tyr1P is mainly associated to promoters in an early, post-initiation step of transcription. 
Although we did not further investigate this possibility, in the accompanying manuscript, Hsin et al 
show that Chicken Tyr1 is found phosphorylated in the nucleoplasm, raising the possibility that Tyr1P 
is also associated with recruitment of the enzyme and transcription initiation.
Genomic profiling at the vicinity of the transcription start site (TSS) indicates two main peaks of Pol 
II upstream and downstream of the TSS (Figure 2D, left panel and Figure 2—figure supplement 4). 
These peaks most likely reflect sense and antisense paused transcription as evidenced by our short 
strand specific (ssRNA) sequencing analysis, as previously described (Core et al., 2008; Preker et al., 
2008; Seila et al., 2008; Fenouil et al., 2012) for mammalian promoters. This transcription results in 
short promoter-associated transcripts production and might relate to pervasive transcription of pro-
moters in sequence context lacking strong elements imposing directionality. By comparing the signals 
of these two peaks with that of the Ser5P and Ser7P isoforms, Tyr1P showed a clearly distinct pattern 
Figure 1. Y1F mutations of the CTD heptads yield a truncated Pol IIB Rpb1. (A) Rpb1-Y1F mutant was expressed 
after removal of tetracycline and in the presence of endogenous Rpb1. Probing with Rpb1 Ab reveals both 
endogenous and recombinant Rpb1 whereas HA reveals only recombinant Y1F mutant. (B) Protein expression of 
the Y1F mutant after shut-down of endogenous Rpb1 following treatment with α-amanitin.
DOI: 10.7554/eLife.02105.003
The following figure supplements are available for figure 1:
Figure supplement 1. Tyr1P is expressed in various human and mouse cell lines. 
DOI: 10.7554/eLife.02105.004
Figure supplement 2. Sequence of the CTD heptads for the Tyr1 to Phe mutant (Y1F). 
DOI: 10.7554/eLife.02105.005
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Figure 2. CTD Tyrosine 1 is phosphorylated mainly at TSS and is dominant in antisense transcription. (A) Co-immunoprecipitation with specific CTD 
isoforms in Raji B-cells reveals Tyr1P (3D12) association with Ser5P and Ser7P but not with Ser2P and Thr4P. (B) ChIP-seq example illustrating Tyr1P (3D12) 
association around the promoter of RPL22L1 gene. (C) Composite average profiling of ChIP-seq data at coding genes locations for Pol II (1433 genes), 
Tyr1P (3D12, 2462 genes), Ser5P (1464 genes), and Ser7P (2186 genes) in Raji B-cells and based on selections described in Figure 2—figure supplement 1B. 
Less stringent selections with more genes gave equivalent profiling (Figure 2—figure supplement 4A). (D) Profiling of Pol II, Tyr1P (3D12), Ser5P, Ser7P, 
nucleosomes midpoint and short strand specific RNAs (ssRNAs) around TSS locations with same selections described in (C). (E) Boxplots on 3201 genes 
without outliers showing mean levels of Pol II (2986 genes), Tyr1P (2964 genes), Ser5P (2909 genes), and Ser7P (2948 genes) ChIP-seq signal on regions 
representing each transcription orientation. The p-values (parametric two sided paired t test) of the difference of AS vs S signal are Pol II = 0.5, 
Tyr1p=3.4 × 10−15, Ser5p=0.6, Ser7p=3.5 × 10−2.
DOI: 10.7554/eLife.02105.006
The following figure supplements are available for figure 2:
Figure supplement 1. Reproducibility of ChIP-seq experiments and selection of relevant signals used for analyses. 
DOI: 10.7554/eLife.02105.007
Figure supplement 2. Pol II and CTD PTMs correlate positively with expression. 
DOI: 10.7554/eLife.02105.008
Figure supplement 3. Examples of Tyr1P binding patterns at genic locations. 
DOI: 10.7554/eLife.02105.009
Figure supplement 4. Average profiling of Pol II and phospho-isoforms at genic and promoter locations using wide relaxed threshold selections. 
DOI: 10.7554/eLife.02105.010
Figure 2. Continued on next page
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with a more pronounced upstream peak (Figure 2D, Figure 2—figure supplement 4 and examples in 
Figure 2—figure supplement 5B). We confirmed this result with an independent Tyr1P antibody (8G5) 
harboring wider range of CTD peptide recognition (Figure 2—figure supplement 7), and by using 
statistical analysis showing that antisense/sense (AS/S) difference was significant for Tyr1P as com-
pared to other isoforms (Figure 2E, Figure 2—figure supplement 4B). Together, our analyses indicate 
that Tyr1P is predominantly associated with upstream polymerases, mostly reflecting AS transcription 
at mammalian promoters.
We previously showed that mammalian promoters associated with Pol II can be grouped in three 
main classes in mouse T-lymphocytes (Fenouil et al., 2012), based on ranking of the main Pol II signal 
from the most upstream to the most downstream of the TSS. We reproduced this result and the main 
features of the three groups in human Raji B-cells by ranking the signal of Tyr1P (Figure 3A, Figure 3—
figure supplement 1A,B). The first class (the majority of genes), with Pol II signals most upstream of TSSs, 
harbors strongly paused Pol II at promoters with high GC content and CpG islands (CGIs) and is associ-
ated with the highest level of bidirectional and AS transcription. The second class, with a sharper Pol II 
peak centered close to the TSS and lower GC content, contains mostly mono-directional sense paused 
transcription whereas the third class contains more downstream Pol II with less pause. We then focused 
our attention on class I that contains most AS short RNAs. In this class, Tyr1P is essentially observed in 
AS while Ser5P, Ser7P, or total Pol II generally show a second peak around the TSS reflecting sense and 
therefore bidirectional transcription (Figure 3C, Figure 3—figure supplement 1C). This indicates that AS 
Tyr1P relates to one specific class of promoters and suggests that in AS orientation, Tyr1P associates 
mainly with the leading edge of Pol II. Pleading for this hypothesis, the location of the AS Tyr1P in class I 
is found more downstream on average as compared to Pol II or Ser5P, and locates just after the −2 nucle-
osome midpoint (Figure 3B,C). A more detailed investigation of the individual positions of phospho- 
isoforms further shows that for the majority of promoters significantly associated with AS short RNAs in 
class I, Tyr1P is either located at the immediate proximity or after the main Pol II peak (Figure 3—figure 
supplement 2) suggesting that it might play a role in early elongation. Although Ser7P displayed similar 
characteristics, its influence on transcription of coding genes is likely to be minor, as Ser7 mutations do not 
show significant phenotype (Chapman et al., 2007) or transcriptome impairment (JCA and DE, unpub-
lished observations). We overall conclude that Tyr1P is a CTD PTM that associates with the 5′ end of genes 
and shows a stronger linkage to paused Pol II at promoters with bidirectional and AS transcription.
Many groups including ours have shown that highly active and tissue-specific enhancers are tran-
scribed by Pol II in various tissues (De Santa et al., 2010; Kim et al., 2010; Koch et al., 2011; Natoli 
and Andrau, 2012). These enhancers can also be hallmarked by the occurrence of H3K4me1high/
H3K4me3low epigenetic marks combination (Koch et al., 2011; Pekowska et al., 2011). To investigate 
if Tyr1P can be detected at enhancers, we first isolated intergenic regions (IGRs) with stringent criteria 
in B-cells using Pol II, H3K4me1, and me3 signals. These were further discriminated from noncoding 
promoters using the relative ratio of H3K4me1/me3 (Pekowska et al., 2011; Li et al., 2012), and from 
both unannotated coding and some long intergenic noncoding genes using the absence of H3K36me3 
that marks gene bodies (Guttman et al., 2009). Using these criteria, we isolated 390 B-cells enhancers 
(Figure 4—figure supplement 1A–D). Our selection was further validated using tissue-specificity anal-
yses (Figure 4—figure supplement 1E) indicating IGRs associated with genes specific to B-cells. 
We next performed profiling of the various Pol II isoforms at these enhancers. As before (Koch et al., 
2011), we observed that these IGRs were associated with Ser5P (Figure 4A) but not with Ser2P Pol II 
(not shown) as well as with short transcripts (reflecting paused transcription) and a discrete nucleo-
some depleted region. Consistent with early elongating Pol II at enhancers, we found signal for both 
Ser7P and Tyr1P at these IGRs. Importantly, Tyr1P appeared more bound to enhancers as compared to 
promoters and total Pol II (Figure 4B,C, Figure 4—figure supplement 2), suggesting that Tyr1 is more 
Figure supplement 5. Ser2P average profile at genic locations and examples of Tyr1P signal at promoter locations. 
DOI: 10.7554/eLife.02105.011
Figure supplement 6. Tyr1P presents a specific pattern of phosphorylation along genes compared to Pol II. 
DOI: 10.7554/eLife.02105.012
Figure supplement 7. Tyr1P specific antibodies with distinct peptide recognition patterns show similar genome-wide profiling at TSS. 
DOI: 10.7554/eLife.02105.013
Figure 2. Continued
Genes and chromosomes | Genomics and evolutionary biology
Descostes et al. eLife 2014;3:e02105. DOI: 10.7554/eLife.02105 6 of 19
Short report
phosphorylated than Ser5 or Ser7 at enhancers and represent a hallmark of these essential areas of the 
genome. Additionally, Tyr1P also displayed the best correlation with Pol II at isolated enhancers 
(Figure 4D). Finally, using an independent selection for active enhancers based on H3K27ac brought 
very similar results (Figure 4—figure supplement 3). Together, our investigations showed that Tyr1P 
Figure 3. Tyr1 is preferentially phosphorylated in antisense orientation on a particular subset of genes. (A) Heatmaps of Tyr1P (3D12), Pol II, Ser5P, Ser7P, 
nucleosome midpoints (positioning) and short strand specific RNAs (red for AS and blue for S signal) at promoters with a significant level of Pol II. 
The genes were ordered by position of the main Tyr1P accumulation area from the most 5′ to the most 3′ within −1000 bp and +1000 bp around TSS. 
Three main classes are defined by Tyr1P occupancy: class I most 5′ (red bar, 1066 genes), class II TSS-proximal (green bar, 579 genes), and class III most 3′ 
(blue bar, 209 genes). (B) Average profiling of short ssRNAs and nucleosomes positions in class I. Positions of the nucleosome midpoints are indicated by 
a dashed line (nucleosome −3, −2, −1, and +1 from left to right). (C) Profiles of Pol II and CTD isoforms in class I. Red, blue, orange, and green dashed 
lines indicate the average position of the maximum values of Pol II, Tyr1P (3D12), Ser5P, and Ser7P signals, respectively. The distance between Pol II 
leading edge and isoforms is indicated below each graph. The borders of nucleosomes −3, −2, and +1 (from left to right) are shown as pink rectangles 
whereas the red, blue, orange, and green circles represent Pol II, Tyr1P, Ser5P, and Ser7P, respectively with indication of directionality based on the short 
ssRNA signals.
DOI: 10.7554/eLife.02105.014
The following figure supplements are available for figure 3:
Figure supplement 1. Three classes of Pol II-bound promoters ordered by Tyr1P location in human Raji cells. 
DOI: 10.7554/eLife.02105.015
Figure supplement 2. CTD isoforms and nucleosome distribution around Pol II upstream of TSSs in class I promoters. 
DOI: 10.7554/eLife.02105.016
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is a strong signature of Pol II-transcribed active enhancers associated with tissue-specific gene 
expression.
Here, we described that Tyr1P associates with 5′ Pol II and AS transcription at promoters and is a 
signature of active, tissue-specific enhancers in human B-cells. These findings contrast with features of 
Figure 4. Tyr1P is a hallmark of enhancers relative to Pol II and promoters signal. (A) Average profiling of Pol II, Tyr1P (3D12), Ser5P, Ser7P, nucleosomes 
occupancy, and short ssRNAs. 390 active putative enhancers (red) and 4618 control promoters (blue) were detected in human Raji B-cells (‘Materials and 
methods–Selection of enhancers and promoters using Pol II’). Profiles are centered on Pol II ChIP-seq maximal signal and are not oriented. (B) Boxplots 
of mean ChIP-seq signal on selected enhancer and control promoter regions for Ser5P (371/4378 values), Ser7P (368/4257 values), and Tyr1P (372/4266 
values). Signals were normalized by the mean ChIP-seq signal of Pol II on the same regions. All marks show a significant difference (nonparametric Mann-
Whitney-Wilcoxon test, p-values <10−10). (C) Example of Tyr1P at promoter and putative enhancer. (D) Spearman cross-correlation between Pol II, Ser5P, 
Ser7P, Ser2P, and Tyr1P (3D12) at intergenic putative enhancers. Tyr1P and Pol II best correlate with each other.
DOI: 10.7554/eLife.02105.017
The following figure supplements are available for figure 4:
Figure supplement 1. Pol II-bound enhancer selection procedure and features. 
DOI: 10.7554/eLife.02105.018
Figure supplement 2. Examples of Tyr1P enhancer association upstream or downstream of CXCR4, DUSP2, and IER5 genes. 
DOI: 10.7554/eLife.02105.019
Figure supplement 3. Selection of enhancers using H3K27ac also shows a dominance of Tyr1P on active and tissue specific enhancers. 
DOI: 10.7554/eLife.02105.020
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Tyr1P in yeast, which is located at gene bodies and proposed to play a role in elongation by impairing 
termination factor recruitment (Mayer et al., 2012). These apparent discrepancies thus provide an 
interesting paradigm whereby a conserved PTM has evolved to display specialized functions specific 
to metazoans. However, S. cerevisiae genes are very compact, mostly devoid of introns and promoters 
structure is also extremely divergent in both length and sequence between yeast (around 100–200 nt, 
AT-rich) and mammals (around 1000 nt, GC-rich). Furthermore, enhancers do not exist per se in yeast. 
In an accompanying manuscript, Hsin et al. (2014) describe similar observations regarding stability of 
Y1F mutant in chicken cells and involvement of Tyr1P in AS transcription at promoters, thus providing 
further evidence that our observations are conserved in vertebrates. We therefore speculate that 
differential CTD PTMs might not only reflect, but also play a role in regulating the directionality of 
transcription. How would Tyr1P behave in organisms with less prominent bidirectional transcription at 
promoters such as Drosophila (Core et al., 2012) thus represents an interesting evolutionary question 
to be addressed in future studies.
Based on the spatial location of Tyr1P in class I promoters, mostly found at the leading edge of Pol II in 
opposite orientation of the gene, it is tempting to speculate that this PTM might be involved in a transcrip-
tional state marking the transition between early and productive elongation, providing a checkpoint for 
transcriptional complexes to proceed in productive elongation. Depending on the level of Tyr1P at pro-
moters, Pol II might become competent for elongation as well as for overcoming the nucleosomal barrier 
both in sense and antisense orientation. Since less Pol II molecules are able to effectively enter elongation 
in AS orientation, more accumulation of the Tyr1P could be observed upstream of the TSS toward the 
leading edge of Pol II. This could also explain degradation of Y1F mutant that is due to absence of Tyr1P 
checkpoint signal, would accumulate around the edge of the promoters and become degraded. Finally 
there could also be a link between hyperphosphorylation of Tyr1 in AS orientation and exosome 
machinery recruitment to degrade nascent RNA prior release of the Pol II enzyme (Preker et al., 2008; 
Andersen et al., 2013). We believe our work will thus provide a new frame of investigation to decipher 
the complexity of mechanisms leading to transcriptional activation, at the heart of gene regulation.
Material and methods
Antibodies
Generation and validation of modification specific mAbs have been described before: Tyr1P mAb 
(3D12, Mayer et al., 2012) and 8G5 (see Figure 2—figure supplement 7), Ser2P (3E10), Ser5P (3E8), 
and Ser7P (4E12, Chapman et al., 2007), Thr4P (6D7, Hintermair et al., 2012).
For further characterization of specificity, the 3D12 and 8G5 Tyr1P antibodies were analyzed in ELISA 
experiments using CTD-like peptides with different modification patterns (Peptide Specialty Laboratories 
GmbH, Heidelberg, Germany) coupled to 96-well maleimide plates (Thermo Fisher Scientific Inc., 
Rockford, IL USA) as antigen (Figure 2—figure supplement 7). Peptides were incubated with the 
monoclonal antibodies and biotinylated, subclass-specific antibodies, respectively. After incubation 
with horseradish peroxidase (HRP)-coupled avidin, H2O2 and TMB (3,3',5,5'-tetramethylbenzidine) 
were added. Absorbance of each well was measured at 650 nm after color change and quantitated 
with an ELISA reader.
Extracts, western blots, and co-immunoprecipitation
Immunoprecipitation (IP) experiments
3 × 106 Raji cells were lysed in 200 µl IP buffer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1% NP-40 
(Roche, Germany), 1x PhosSTOP (Roche), 1x protease inhibitor cocktail (Roche)) for 20 min on ice. 
All samples were sonicated on ice using a BRANSON Sonifier 250 (15 s on, 15 s off, 50% duty) and 
centrifuged at 14,500 rpm for 15 min at 4°C. The supernatant was incubated with antibody-coupled 
protein G/A-sepharose (1:1) beads (2.5 µg of antibodies for 4 hr at 4°C, followed by two washes with 
1 ml IP buffer) rotating overnight. Beads were washed several times with 1 ml IP buffer and proteins 
were boiled off Sepharose beads in Laemmli buffer containing 8M urea for SDS-Page.
Western blots
Samples of protein were harvested following treatment using 2x Laemmli buffer. Protein equivalent to 
200,000 cells was loaded in 20 µl Laemmli, per lane, and subjected to SDS-PAGE on a 6.5% gel before 
transfer to nitrocellulose (GE Healthcare, Germany). Membranes were either stained with affinity 
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purified, IR-labelled secondary antibodies against rat (680 nm; Alexa, Invitrogen) and mouse (800 nm; 
Rockford, Biomol), and revealed using the Odyssey (Licor), or stained with hrp-conjugated secondary 
antibodies against rat (Sigma), mouse (Promega), or rabbit (Promega), and revealed by enhanced 
chemiluminescence.
Generation and analysis of Y1F mutant
Construction of the CTD Y1F mutant
Construction of wild-type and mutant (Y1F) Rpb1 expression vectors was performed as follow: The 
DNA sequence of RPB1 CTD comprising amino acids of repeats 1–52 (aa 1593–1970) was synthesized 
and cloned into a vector LSmock (Chapman et al., 2004) and recombinant HA-tagged wild-type RPB1 
was established. Alternatively, a CTD DNA sequence was synthesized with a replacement of amino acid 
tyrosine to phenylalanine in repeats 4 to 51 of CTD. Both vectors were sequenced before usage.
α-Amanitin resistant cell lines and cell culture
Raji is an Epstein-Barr-virus-positive Burkitt's lymphoma cell line. Cells were transfected with the wild-
type and (Y1F) Rpb1 expression vectors by electroporation (10 μg of plasmid DNA/107 cells; 960 μF, 
250 V). Polyclonal cell batches were established after selection with G418 (1 mg/ml) for 10–12 days. 
Expression of recombinant Rpb1 was induced by removal of doxocyclin. 24 hr after induction, cells 
were cultured in the presence of 2 μg/ml α-amanitin (Sigma). Cells were grown in RPMI 1640 medium 
supplemented with 10% fetal calf serum, 1% penicillin streptomycin (GIBCO; Invitrogen, Germany), 
and 2 mM L-glutamine (GIBCO; Invitrogen) at densities between 2 × 105 to 106 cells/ml.
ChIP-seq, MNase-seq, and RNA-seq experiments
ChIP-seq and MNase-seq experiments were performed essentially as described before using same 
standard and QC for experiments (Fenouil et al., 2012). Experimental details of individual experiments, 
including replicates when applicable, are also indicated in Table 1.
ChIP-seq
Briefly, for ChIP-seq experiments, Raji B-cells were directly crosslinked in 25 ml of growth medium. 
Crosslinking was performed with the addition of 1/10th volume of crosslinking solution (11% form-
aldehyde, 100 mM NaCl, 1 mM EDTA pH 8, 0.5 mM EGTA pH 8, 50 mM Hepes pH 7.8) for a final 
formaldehyde concentration of 1% for 10 min at room temperature. The reaction was quenched with 
the addition of 250 mM glycine and incubation at room temperature for 5 min. Cells were washed 
twice with cold DPBS and counted. All buffers contained EDTA-free protease inhibitor cocktail (Roche, 
France) and phosphatase inhibitors (Thermo Scientific, France) to final concentration of 1x together 
with 0.2 mM PMSF and 1 µg/ml pepstatin. 5 × 107 cells were then lysed in 2.5 mL LB1 buffer (50 mM 
Hepes pH 7.5, 140 mM NaCl, 1 mM EDTA pH 8, 10% glycerol, 0.75% NP-40, 0.25% Triton X-100) by 
incubation at 4°C for 20 min. Nuclei were collected by centrifugation at 1350×g and washed in 2.5 ml 
LB2 (200 mM NaCl, 1 mM EDTA pH 8, 0.5 mM EGTA pH 8, 10 mM Tris pH 8) for 10 min. Nuclei were 
then centrifuged and resuspended in 1.5 ml of LB3 (1 mM EDTA pH 8, 0.5 mM EGTA pH 8, 10 mM 
Tris pH 8, 100 mM NaCl, 0.1% Na-Deoxycholate, 0.5% N-lauroylsarcosine) and sonicated using a 
Misonix 4000 (Misonix Inc, Farmingdale, NY, USA) sonicator for 14 cycles of 30 s ON and 30 s OFF 
at amplitude of 40. After sonication Triton X-100 was added to 1% final concentration and cellular 
debris was precipitated by centrifugation at 20000×g for 10 min in a refrigerated centrifuge. 
Aliquots of clear supernatant were transferred to new tubes, snap frozen, and kept at −80°C until 
use. 50 µl aliquots were taken to serve as input control as well as sonication quality control.
Inputs were combined with an equal volume of 2x elution buffer (100 mM Tris pH 8, 20 mM EDTA 
pH 8, 2% SDS) and incubated overnight in a water bath at 65°C for 13–15 hr. SDS was then diluted by 
the addition of an equal volume of TE (10 mM Tris pH 8, 1 mM EDTA pH 8) and RNA was digested by 
RNase A at a final concentration of 0.2 μg/ml at 37°C for 2 hr. Samples were subsequently Proteinase 
K treated at 55°C for 2 hr at a final concentration of 0.2 μg/ml. DNA was purified by two subsequent 
phenol:chloroform:isoamylalcohol (25:24:1, pH 8) extractions and followed by a Qiaquick purification 
(PCR purification columns, Qiagen, Germany). DNA concentration was measured using a Nanodrop 
1000 (Thermo Scientific, France) and 4 ng DNA was analyzed using High Sensitivity DNA chips on a 
2100 Bioanalyzer to verify sonication efficiencies.
All experiments were performed using Dynabeads (Invitrogen, USA) coated with Protein-G. Beads 
were washed 3x with 1 ml and subsequently resuspended in 250 μl of blocking solution (0.5% BSA in 
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1x DPBS). After the addition of the antibody, the beads were incubated at 4°C overnight on a rotating 
wheel. Unbound antibodies were removed through three further washes with 1 ml of blocking 
solution. Beads were resuspended in 100 μl of blocking solution, chromatin extracts were added, 
and the mix was incubated overnight at 4°C on a rotating wheel.
EDTA-free protease inhibitors (Roche) were added to all washing buffers to a final concentration 
of 1x together with 0.2 mM PMSF and 1 μg/ml pepstatin. Beads were washed 8 times in RIPA buffer 
(50 mM Hepes pH 7.6, 500 mM LiCl, 1 mM EDTA pH 8, 1% NP-40, 0.7% Na-Deoxycholate) and once 
in TE+ (10 mM Tris pH 8, 1 mM EDTA pH 8, 50 mM NaCl). Immunoprecipitated chromatin was recov-
ered from the beads with two subsequent elution steps at 65°C for 15 and 10 min in 110 μl and 100 μl 
of elution buffer (50 mM Tris pH 8, 10 mM EDTA pH 8, 1% SDS), respectively. The two eluates were 
combined and incubated at 65°C overnight (13–15 hr) for crosslink reversal. DNA was purified as 
described for the input (see Table 1 for a summary of ChIP conditions for each experiment).
Prior to sequencing, ChIP DNA was quantified using the double stranded DNA HS kit on a Qubit 
apparatus (Life Technologies, USA) and 1 ng ChIP DNA was analyzed on a High Sensitivity DNA chip 
on a 2100 Bioanalyzer (Agilent Technologies, USA). DNA yields were typically between 5 and 100 ng for 
different antibodies. At least 1 ng of ChIP or input DNA was used for library preparation according to the 
Illumina ChIP-seq protocol. After end-repair and adapter ligation, fragments were size-selected (cut) on 
an agarose gel prior to pre-amplification and clustering. The size-selected and pre-amplified fragments 
were verified on a 2100 Bioanalyzer (Agilent Technologies, USA) before clustering and sequencing on 
a Genome Analyzer II or HighSeq 2000 (Illumina, USA) according to manufacturer's instructions.
MNase-seq
For sequencing of nucleosomal DNA, 2 × 107 cells were resuspended in 50 μl Solution I (150 mM sucrose, 
80 mM KCl, 5 mM K2HPO4, 5 mM MgCl2, 0.5 mM CaCl2, 35 mM HEPES pH 7.4) and NP40 was added to 
a final concentration of 0.2%. Cell membranes were permeabilized for one minute at 37°C. For nucleo-
somal digestion, 40U of MNase was added with 0.5 ml of Solution II (150 mM sucrose, 50 mM Tris pH 8, 
50 mM NaCl, 2 mM CaCl2) and incubated for 30 min at room temperature. The reactions were stopped 
with the addition of EDTA to a final concentration of 10 mM. The cells were lyzed using 1.45 ml of SDS 
Lysis Buffer (1% SDS, 10 mM EDTA pH 8, 50 mM Tris pH 8), with a 10 min incubation at 4°C. A 200 μl 
aliquot was taken for purification and the remaining extract was stored at −80°C. An equal volume of TE 
(200 μl) was added to the aliquot, followed by subsequent 2 hr treatments with each 0.2 μg/ml final 
concentrations of RNase A and Proteinase K at 37°C and 55°C, respectively. DNA was extracted by two 
subsequent phenol:chloroform:isoamylalcohol (25:24:1) extractions, further purified using QIAquick PCR 
purification columns (Qiagen, Germany) and eluted in 50 μl of water. The quality of nucleosomal diges-
tion was verified by running 2 ng of DNA on High-Sensitivity 2100 Bioanalyzer chips (Agilent, USA). The 
typical Bioanalyser profile in our standardized conditions shows a clear peak of mononucleosome at 
146 −/+ 5 bp that represents 80% of the nucleosomal DNA (the rest of the digested material spreads 
essentially in di- and tri-nucleosomal DNA). After library preparation, DNA fragments corresponding to 
mononucleosomes were cut from an agarose gel and subsequently clustered and sequenced on Genome 
Analyzer II (Illumina, USA) according to manufacturer's instructions.
Short strand specific RNA-seq
Total RNA was extracted from 1 × 107 Raji cells using TRIzol (Life Technologies, USA) according to the 
manufacturer's instructions with some modifications to ensure higher recovery rates of small RNAs. 
This was achieved by addition of 10 μg of linear acrylamide (Life Technologies, USA) before RNA 
precipitation. DNA was digested using the rigorous Turbo DNase (Ambion, USA) treatment as per 
manufacturer's instructions. RNA quantity was measured on a Qubit apparatus (Life Technologies, 
USA) using RNA assay kit and the quality was verified using RNA pico chips on a 2100 Bioanalyzer 
(Agilent Technologies, USA).
Before preparation of sequencing libraries, small RNAs were enriched from 10 µg total RNA by using 
mirVana RNA Isolation kit (Life Technologies, USA) using manufacturer's protocol for small RNA enrich-
ment. Strand specific RNA-seq library was constructed with ScriptMiner Small RNA-seq Library Preparation 
Kit (Epicenter, USA) according to manufacturer's recommended protocol. Briefly, after both 5′ and 3′ 
adapter ligation, resulting cDNA library was PCR amplified with 14 amplification cycles. Purified library 
DNA was run on a 10% TBE-PAGE gel and library DNA corresponding to transcripts between 15 nt 
and 50 nt was cut from the gel and transferred into 0.5 ml tubes with punctured bottoms which were 
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in turn placed in 2 ml collection tubes. Gel slices were crushed into 2 ml tubes by a 2 min centrifugation 
at 14000×g. For library DNA elution by soaking, 0.4 ml of 0.3M NaCl was added to each tube, before 
a 4 hr rotation at room temperature. After removal of gel particles using 0.22 μm cellulose acetate 
filters, 10 μg of linear acrylamide (Life Technologies, USA) and 2.5 vol (approximately 1 ml) of ice-cold 
absolute ethanol were added. After 30 min incubation at −80°C, the eluted cDNA was precipitated by 
centrifugation at 4°C and maximum speed for 45 min. The pellet was washed with 1 ml of cold 80% 
ethanol, air dried, and resuspended in 20 μl of water. The size-selected small RNA library DNA was 
quantified using a Qubit apparatus with dsDNA High Sensitivity kit (Life Technologies, USA) and veri-
fied using DNA High Sensitivity 2100 Bioanalyzer chips (Agilent Technologies, USA). The library was 
clustered and sequenced using 76 cycles on a Genome Analyzer II (Illumina, USA) according to manu-
facturer's instructions.
Data pre-processing
Details of the data pre-processing are described in Fenouil et al. (2012).
Quality control and filtering
In brief, all samples were sequenced on an Illumina Genome Analyzer (GAIIx for ChIP-seq and RNA-
seq, or HIseq2000 for MNase-seq and H3K27ac). Quality assessment and filtering of ChIP-seq and 
MNase-seq sequences were performed using either the Integrated Eland software or FASTX-Toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit/index.html) to pre-process FastQ files. Quality score and 
nucleotide composition at each position of the sequenced tags were assessed by box and bar plotting 
using FastX-Toolkit standard functions.
Quality controls (QC) and filtering of RNA samples were performed using fastQC (http://www.
bioinformatics.babraham.ac.uk/projects/fastqc/), FASTX-toolkit, and Cutadapt (http://code.google.
com/p/cutadapt/). Adapters were removed (Cutadapt) and a QC report was generated (fastQC). Sequences 
were further trimmed at nucleotide 55 and quality filtered as for DNA sample (FASTX-toolkit).
Processing of sequenced tags
All samples were aligned to human genome (hg19, GRCh37) using Bowtie (Langmead et al., 2009) 
aligner (allowing two mismatches, keeping uniquely aligned reads only). Number of tags used are 
shown in Table 1. For technical replicates, Eland aligned files or BAM files were merged and processed 
as described in Fenouil et al. (2012). Correlations between biological replicates used in this study 
are shown in Figure 2—figure supplement 1A. Whenever 2 replicates were not fitting a minimal 
good signal/noise or reproducible signal, samples were discarded from analysis and experiment repro-
duced. For the processing, briefly, piles of tags with same coordinates, due to artifacts of PCR or 
unannotated regions of the genome were removed according to a thresholding method, except 
for RNA-seq experiment. Uniquely aligned tags were further elongated after estimating optimal elon-
gation size in silico and enabling to use the original fragment length for further processing. For ChIP-
seq experiments, all samples were input subtracted and signals were scaled. For nucleosome mapping, 
MNAse-seq experiment in Raji was sequenced in paired-end with higher depth than ChIP-seq in 
Hiseq2000. Two types of analyses were applied to this data: nucleosomes density (Figure 4A, Figure 3—
figure supplement 1) and nucleosomes midpoint (Figure 2D, Figure 3, Figure 3—figure supplement 1) 
that allow to score more specifically for depletion or positioning, respectively. For nucleosome density, 
paired tags were processed so to be directly connected and to retrieve original fragments (orphan 
tags were connected to the corresponding pairs using the estimated elongation size computed as 
described above). The input subtraction step was omitted. For nucleosomes midpoint analyses, the 
middle of elongated fragments was set as reference allowing locating the maximum signal approxi-
mately at the midpoint of the nucleosomes (dyads). For all experiments, the number of tags covering 
each nucleotide of the genome was computed and averaged in bins of 50 nucleotides and in bins of 
10 (Figure 3—figure supplement 2C). The scores of bins were rescaled (after input subtraction when 
applicable) to reduce over-representation of particular genomic regions and signal/noise ratio. Finally, 
wig files of each corresponding biological replicates were merged.
Bioinformatics analysis
Gene selection and average binding profiles
Wiggle files scores were retrieved with an in-house R script (Source code 1) for hg19 Refseq annota-
tions and coordinates defined for selected enhancers and promoters. Overlapping annotations 
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and those being at less than 2000 bp of another were removed. Indeed, keeping genes in vicinity 
of others could mix different signals leading to misinterpretation. To select Refseq genes with a 
significant signal, mean values distributions of Pol II isoforms and short ssRNAs at (TSS-1000 bp; 
TES+2000 bp) (whole gene, Figure 2C,D, Figure 2—figure supplement 5A, Figure 2—figure 
supplement 6A) and at TSS −/+500 bp (TSS, Figure 3, Figure 3—figure supplement 1, Figure 3—
figure supplement 2) were plotted using an in-house script (Figure 2—figure supplement 1B,C, 
Source code 1). Gene sets of Figure 2 were selected according to each experiment mean distribu-
tion except for MNase-seq and RNA-seq whose selections were based on Pol II. For Figure 2—figure 
supplement 4, a less stringent threshold at 0 was used in order to study phosphorylation patterns 
of lower bound genes. The set of genes used in Figure 3 were also selected according to levels 
of Pol II at TSS (Figure 2—figure supplement 1C). Based on distribution, two Gaussian distribu-
tions were fitted using the R package mixdist (http://www.math.mcmaster.ca/peter/mix/mix.html). 
The threshold above which a mean value is considered as significant was set to the mean of the 
second Gaussian distribution. In these analyses, only genes with a length above 2 kb were kept as 
shorter genes tend to harbor specific profiles not reflecting the majority of coding sequences, for 
examples due to shorter (or lack of) introns. Moreover, histone, rRNA, snomiRNA, snoRNA, snRNA, 
and tRNA genes as well as outliers of short ssRNAs were removed since they also potentially modify 
the shapes of average profiles. Finally, a total of 1854 genes was used in Figure 3 (1846 without 
antisense RNA outliers).
An in-house R package retrieves signal of ChIP-seq, RNA-seq, and MNase-seq, centers them at TSS 
and transcription end site (TES) on a user defined selection of genes and intervals. It also retrieves all 
values inside each annotation, scale them to the same length, and add the half of values computed 
around TSS upstream and around TES downstream the annotation to obtain profiles as shown in 
Figure 2C. Rescaling and plotting are obtained by interpolating the retrieved values on 1000 points 
enabling to build a matrix on which each column will be averaged. In Figure 2—figure supplement 6A, 
the values were further divided into three curves representing average profiles of the top 5%, top 
5–20%, and bottom 5% of genes signal.
Boxplots and statistical tests
The in-house package mentioned above was used to retrieve values on which means were computed. 
The boxplots of Figure 2E represent two sets of mean values computed on: the antisense region 
which was defined as covering 500 bp before TSS and the sense region as covering 500 bp after. 
The analysis was performed on 3201 genes defined as being the union of the set of genes retrieved 
for each mark. The outliers defined by the R function ‘boxplot’ by default as being all values above 
Q3+(1.5 × (Q3−Q1)) (interquartile range) were filtered. The remaining values were scaled between 0 
and 1 before plotting. Before performing the parametric two-sided paired sample t test (Source code 1), 
the normal distribution of data was checked (data not shown). In Figure 2—figure supplement 2D, 
the same method was used on lowly, medium, and highly expressed genes without scaling between 
0 and 1 but instead dividing by the binding values of Pol II.
Figure 2—figure supplement 2C represents mean values computed as mentioned above using 
only one region −/+500 bp around TSSs without removing outliers and scaling. However, outliers were 
not represented. The boxplots in Figure 4B, Figure 4—figure supplement 1D, and Figure 4—figure 
supplement 3C,D were computed similarly and divided by the corresponding mean values of Pol II. 
No mean values of Pol II equal to zero were detected.
Tyr1P peak sorting and corresponding clusters
For Tyr1P sorting (Figure 3, Figure 3—figure supplement 1), an in-house script (Source code 1) was 
used as described previously in Fenouil et al. (2012). Briefly, taking the genes selected as having sig-
nificant level of Pol II, genes were ordered according to the relative increasing distance to the TSS of 
the maximal peak of Tyr1P. Other clusters show the corresponding signal of Pol II, Ser5P, Ser7P, nucle-
osomes, and short ssRNAs on the same genes. Heatmaps were formatted in terms of color and 
contrast according to sample read depth using Java TreeView software (Saldanha, 2004).
Definition of AT/GC content and density map
The AT content defines the presence of A or T in a particular sequence. Similarly, the GC content 
defines the presence of G or C in a given sequence.
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The heatmaps of Figure 3—figure supplement 1A (AT and GC content) were built as follow: 
The corresponding fasta sequences of genes used in Figure 3 were retrieved with the R package 
ChIPpeakAnno (Zhu et al., 2010) in association with the Bioconductor package BSgenome.
Hsapiens.UCSC.hg19 (http://www.bioconductor.org/packages/2.12/data/annotation/html/BSgenome. 
Hsapiens.UCSC.hg19.html). The command line RSAT tools (Turatsinze et al., 2008) enabled to 
retrieve the motifs W (A or T) and S (G or C) from those sequences. With an in-house script (Source 
code 1), the positions of motifs were converted to GFF formatted files taking into account the posi-
tions of Refseq hg19 annotations. Finally, another in-house script (Source code 1) converted those 
GFF to a binary matrix that was output in a format readable by Java Treeview software. This software 
was used as described above for color scaling.
Correlation of biological replicates and cross-correlation
In Figure 4D, mean values used for Spearman correlation were retrieved on selected enhancer regions 
(+/−2000 bp around Pol II ChIP-seq maximal signal). In Figure 2—figure supplement 1, each point 
represents the mean value of ChIP-seq signal of a gene on interval [TSS-1000 bp;3′+1000 bp]. For 
Figure 4—figure supplement 3, cross-correlation were computed −/+ 500 bp around H3K4me3 
ChIP-seq maximal signal. Finally for Figure 2—figure supplement 6B, from left to right, Spearman 
correlations were computed on mean values at [TSS−500 bp;TSS+500 bp], [TSS+1000 bp;3'−500 bp], 
and [3′−500 bp;3'+1000 bp], respectively. The scripts for generating the correlations of biological 
replicates and tables of cross-correlation are available in Source code 1.
Selection of enhancers and promoters using Pol II
For the analyses shown in Figure 4 and Figure 4—figure supplement 1 (scripts and procedure to detect 
enhancers and promoters can be found in Source code 1), wiggle files of ChIP-seq signals of Pol II, 
H3K4me1, H3K4me3, and H3K36me3 were analyzed to extract enriched regions at control promoters 
and putative intergenic enhancers. The peak-calling was performed using an in-house script (Source code 1) 
fixing a threshold based on the peak height and the gap between two adjacent signals. Enriched 
regions separated by a distance less than a fixed max gap were merged (chosen values of thresholds and 
max gap are summarized in Table 1). Regions showing a combined enrichment of Pol II, H3K4me1, and 
H3K4me3 signal were further identified as regions of interest to build control promoters and putative 
intergenic enhancer sets (Figure 4—figure supplement 1A–E1P1). When a region intersected a gene 
annotation on the interval [TSS−2000; TSS+1000], it was defined as a ‘promoter region’ (6073 regions). 
To refine enhancer selection and to avoid lincRNAs promoter regions (Guttman et al., 2009; Natoli and 
Andrau, 2012), we removed the regions located at less than 5000 bp from any hg19 Refseq gene and 
harboring a significant H3K36me3 signal enrichment in vicinity that is less than 2000 bp from boundaries 
(747 regions, Figure 4—figure supplement 1A–E2). We further used the H3K4me3/me1 ratio to define 
final enhancer and promoter selections (Pekowska et al., 2011; de Almeida et al., 2011; Li et al., 2012; 
Natoli and Andrau, 2012). Means and relative ratios of ChIP-seq signal of H3K4me1 and H3K4me3 on 
intergenic enhancer candidates, on promoter candidates, and on corresponding annotated hg19 Refseq 
promoters (extended by ±1000 bp) were computed (Figure 4—figure supplement 1B). A threshold 
(green dashed line, Figure 4—figure supplement 1B) was defined to remove intergenic enhancer can-
didate regions with a H3K4 methylation ratio signature similar to promoters (ratio above the threshold), 
leading to a selection of enhancers (422 regions, Figure 4—figure supplement 1A–E3). Similarly, pro-
moter candidates with H3K4me3 over H3K4me1 ratio below the fixed threshold were removed from the 
selection (5812 regions remaining, Figure 4—figure supplement 1A–P2).
In identified promoters and enhancers sets, the location of maximal signal of Pol II was defined as 
the centre of the region. Finally, mean values of short ssRNA signal were computed on each promoter 
and enhancer at centers of the regions ± 2000 bp around Pol II peak. The enhancers and promoters 
with outlying values were filtered from selections (390 enhancers and 4618 promoters remaining, 
Figure 4—figure supplement 1AE4P3). Note that using Pol II as a docking site for these analyses 
typically yields a rather strong nucleosome density at the middle of the promoter/enhancer area 
(Figure 4A). Different results can be obtained (lower nucleosome densities) when TBP is used as a 
docking site (de Almeida et al., 2011).
Selection of active enhancers and promoters using H3K27ac
Similarly to the previous section (see also Source code 1), enhancers and promoters were selected using 
detected peaks of H3K4me1, H3K4me3, H3K36me3, and H3K27ac (Figure 4—figure supplement 3A). 
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This selection enables distinguishing active enhancers and promoters (having an overlapping peak 
of H3K27ac) from the whole selection (based on H3K4me1/3 that includes less active or poised 
enhancers). Although Pol II was described to be a hallmark of active and tissue specific enhancers 
(Koch et al., 2011), the here below described procedure enabled to retrieve a higher number of 
enhancers (2598; 927 active) and promoters (6057; 5946 active) giving a less stringent description 
of these genomic modules.
Regions harboring H3K4me1 and H3K4me3 were first split into intergenic regions without 
H3K36me3 (E2′, 3404) and promoter regions (P1′, 8201). Using the ratio H3K4me1/H3K4me3, 2789 
enhancers (E3′) and 7147 promoters (P2′) were kept. Performing H3K27ac overlap on the above 
isolated regions yields 1045 active enhancers and 7030 active promoters. Regions were centered 
on H3K4me3 maximal values and discarding regions having short RNAs outliers finally gives active 
enhancers and control promoters (E5′/P5′, 927/5946) and a whole set of enhancers and control 
promoters (E6′/P6′, 2598/6057).
Tissue specificity analysis
To assess the tissue specificity of genes associated with identified enhancers and promoters 
of Figure 4 (Figure 4—figure supplement 1E) and Figure 4—figure supplement 3C,D, we pro-
ceeded as in Koch et al. (2011). Briefly, using bioGPS website (http://biogps.org/#goto=welcome), 
a Gene Atlas averaged dataset of expression values based on HGU133 array for human containing 
84 tissues (Su et al., 2004) was used. The expression values of genes nearest to selected enhanc-
ers and promoters were compared to the whole dataset and the significance of differences was 
assessed with a nonparametric statistical Mann-Whitney-Wilcoxon test. Bars of expression levels 
were sorted by p-values and the 10 most differentially expressed tissues are shown. Scripts gener-
ating the tissue specificity barplots are available in Source code 1.
Gene expression analysis
Microarrays data of expression in Human Raji cell line was retrieved on Array Express database 
(E-GEOD-46873). Corresponding symbols between array chip and human hg19 Refseq annotations 
were downloaded from Ensembl Biomart (Release 73, Flicek et al., 2013).
Replicates were merged by taking the mean of expression. When several probes indicated 
expression of a single Refseq gene, the median of expression was attributed to the corresponding 
Refseq ID. Refseq genes were then ordered by expression removing genes at less than 2 kb from 
another and particular categories of genes were removed as described in ‘Materials and methods–
Gene selection and average binding profiles’. Corresponding ChIP-seq and short ssRNA-seq 
signals were retrieved on the ordered genes and represented with heatmaps at 1 kb around TSS 
(Figure 2—figure supplement 2). For profiles shown in Figure 2—figure supplement 2B, outliers 
were discarded. As mentioned above, colors were scaled using Java Treeview software. Profiles 
(Figure 2—figure supplement 2B) and boxplots (Figure 2—figure supplement 2CD) were built 
as described in ‘Materials and methods–Gene selection and average binding profiles and Boxplots 
and statistical tests’. Input files and scripts used can be found in Source code 1.
CTD isoforms and nucleosomes midpoint maximal peaks spatial 
organization analysis
Binary matrices of 2000 interpolated ChIP-seq values shown in Figure 3A and Figure 3—figure 
supplement 1A in Java Treeview format were used as input. They were reduced to values at ± 500 bp 
around TSS and the list of genes limited to group 1. Maximal value indexes of Tyr1P signal were 
first retrieved. To avoid ambiguities in interpretation in our relative Pol II and isoforms positions in 
class I (Figure 3—figure supplement 2), we analyzed those genes that belonged to class I and that 
clearly featured AS transcription. For this, mean values of short ssRNA experiments were computed at 
−50/+100 bp around Tyr1P detected maximal peaks. Genes having a significant level of antisense 
RNAs were kept using the mean distribution and thresholding as described in ‘Materials and 
methods–Gene selection and average binding profiles’. Only annotations with a level of antisense 
RNAs higher than sense RNAs were kept performing a one sided nonparametric Mann-Whitney-
Wilcoxon statistical test (p-value <0.05). A total of 529 genes were selected. Then, maximal peaks 
detection for the other marks was computed at −100/+100 bp around Tyr1P signal. For each maximal 
peak of each experiment shown in Figure 3—figure supplement 2, the distances to maximal peaks 
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of Tyr1P and Pol II were computed. The R package rgl (http://rgl.neoscientists.org/about.shtml) 
was used for 3D representation of the maximal peaks according to the distance to TSS, to Pol II 
and their values.
To assess if distances retrieved were not originating from background noise (Figure 3—figure 
supplement 2C), distances to Pol II of selected genes of (A) on 500 bp before TSS (representing 
the AS region) were compared to the total set of genes (keeping only genes at more than 2000 bp 
from any RefSeq annotations). Kernel density estimates were computed using R. A lower resolution of 
10 bp was used (compared to 50 bp of Figure 3—figure supplement 2A,B). Scripts and procedures 
to generate figures of the spatial analysis can be found in Source code 1.
Acknowledgements
Members of the Jean Christophe Andrau's lab were supported by grants for ANR (Muhammad 
Ahmad Maqbool, Lionel Spinelli), CNRS (Romain Fenouil), FRM (Charlène Innocenti), Ministère de la 
Recherche (Nicolas Descostes) and Ligue Nationale contre le Cancer (Nicolas Descostes). Work in 
the Dirk Eick's lab was supported by Deutsche Forschungsgemeinschaft Grants SFB1064 and 
SFB684. We thank Salvatore Spicuglia for suggestion in the manuscript. We thank Jim Manley and 
colleagues for communicating their manuscript prior submission. We thank also Pierre Ferrier for his 
advice and support.
Data accession




Funder Grant reference number Author
Agence Nationale de la 
Recherche  
Lionel Spinelli,  
Muhammad Ahmad Maqbool




Ministère de la Recherche/ 





SFB1064 and SFB684 Martin Heidemann,  
Roland Schüller, Dirk Eick
The funders had no role in study design, data collection and interpretation, or the decision  
to submit the work for publication.
Author contributions
ND, Performed bioinformatic analyses, Conception and design, Analysis and interpretation of data, 
Drafting or revising the article, Contributed unpublished essential data or reagents; MH, Involved in 
antibody generation and biochemical characterization, Conception and design, Acquisition of data, 
Drafting or revising the article, Contributed unpublished essential data or reagents; LS, Performed 
bioinformatic analyses, Analysis and interpretation of data, Drafting or revising the article; RS, 
Involved in antibody generation and biochemical characterization, Acquisition of data, Drafting or 
revising the article; MAM, Performed genome-wide experiments, Conception and design, Acquisition 
of data, Drafting or revising the article, Contributed unpublished essential data or reagents; RF, 
Performed bioinformatic analyses, Analysis and interpretation of data, Drafting or revising the article, 
Contributed unpublished essential data or reagents; FK, Performed genome-wide experiments, 
Acquisition of data, Drafting or revising the article, Contributed unpublished essential data or reagents; 
CI, Performed genome-wide experiments; MG, IG, Performed sequencing at the CNAG platform, 
Acquisition of data; DE, J-CA, Conception and design, Acquisition of data, Analysis and interpreta-
tion of data, Drafting or revising the article, Contributed unpublished essential data or reagents
Genes and chromosomes | Genomics and evolutionary biology




• Source code 1. Folder containing the different scripts used in this study.
DOI: 10.7554/eLife.02105.022
Major datasets
The following datasets were generated:




Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA,  
Fenouil R, Koch F, Innocenti C,  
Gut M, Gut I, Eick D, Andrau J
2014 Pol II http://www.ncbi.nlm.nih.gov/ 
geo/query/acc. 
cgi?acc=GSE52914
Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA,  
Fenouil R, Koch F, Innocenti C,  
Gut M, Gut I, Eick D, Andrau J
2014 H3K4me1 http://www.ncbi.nlm.nih.gov/ 
geo/query/acc. 
cgi?acc=GSE52914
Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA,  
Fenouil R, Koch F, Innocenti C,  




Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA, 
Fenouil R, Koch F, Innocenti C,  




Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA, 
Fenouil R, Koch F, Innocenti C,  




Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA, 
Fenouil R, Koch F, Innocenti C,  




Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA,  
Fenouil R, Koch F, Innocenti C,  




Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA,  
Fenouil R, Koch F, Innocenti C,  




Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA,  
Fenouil R, Koch F, Innocenti C,  




Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA,  
Fenouil R, Koch F, Innocenti C,  
Gut M, Gut I, Eick D, Andrau J
2014 short RNAs http://www.ncbi.nlm.nih.gov/
geo/query/acc.
cgi?acc=GSE52914
Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA,  
Fenouil R, Koch F, Innocenti C,  




Publicly available at 
NCBI Gene Expression 
Omnibus.
Descostes N, Heidemann M,  
Spinelli L, Schüller R, Maqbool MA, 
Fenouil R, Koch F, Innocenti C,  




Publicly available at 
NCBI Gene Expression 
Omnibus.
References
Andersen PR, Domanski M, Kristiansen MS, Storvall H, Ntini E, Verheggen C, Schein A, Bunkenborg J, Poser I, 
Hallais M, Sandberg R, Hyman A, LaCava J, Rout MP, Andersen JS, Bertrand E, Jensen TH. 2013. The human 
Genes and chromosomes | Genomics and evolutionary biology
Descostes et al. eLife 2014;3:e02105. DOI: 10.7554/eLife.02105 18 of 19
Short report
cap-binding complex is functionally connected to the nuclear RNA exosome. Nature Structural & Molecular 
Biology 20:1367–1376. doi: 10.1038/nsmb.2703.
Buratowski S. 2009. Progression through the RNA polymerase II CTD cycle. Molecular Cell 36:541–546.  
doi: 10.1016/j.molcel.2009.10.019.
Chapman RD, Heidemann M, Albert TK, Mailhammer R, Flatley A, Meisterernst M, Kremmer E, Eick D. 2007. 
Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science 318:1780–1782. doi: 10.1126/
science.1145977.
Chapman RD, Palancade B, Lang A, Bensaude O, Eick D. 2004. The last CTD repeat of the mammalian  
RNA polymerase II large subunit is important for its stability. Nucleic Acids Research 32:35–44. doi: 10.1093/
nar/gkh172.
Core LJ, Waterfall JJ, Gilchrist DA, Fargo DC, Kwak H, Adelman K, Lis JT. 2012. Defining the status of RNA 
polymerase at promoters. Cell Reports 2:1025–1035. doi: 10.1016/j.celrep.2012.08.034.
Core LJ, Waterfall JJ, Lis JT. 2008. Nascent RNA sequencing reveals widespread pausing and divergent initiation 
at human promoters. Science 322:1845–1848. doi: 10.1126/science.1162228.
de Almeida SF, Grosso AR, Koch F, Fenouil R, Carvalho S, Andrade J, Levezinho H, Gut M, Eick D, Gut I, Andrau JC, 
Ferrier P, Carmo-Fonseca M. 2011. Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation 
of histone H3 Lys36. Nature Structural & Molecular Biology 18:977–983. doi: 10.1038/nsmb.2123.
De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, Muller H, Ragoussis J, Wei CL, Natoli G. 2010. 
A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLOS Biology 8:e1000384. 
doi: 10.1371/journal.pbio.1000384.
Egloff S, O'Reilly D, Chapman RD, Taylor A, Tanzhaus K, Pitts L, Eick D, Murphy S. 2007. Serine-7 of the RNA 
polymerase II CTD is specifically required for snRNA gene expression. Science 318:1777–1779. doi: 10.1126/
science.1145989.
Fenouil R, Cauchy P, Koch F, Descostes N, Cabeza JZ, Innocenti C, Ferrier P, Spicuglia S, Gut M, Gut I, Andrau JC. 
2012. CpG islands and GC content dictate nucleosome depletion in a transcription-independent manner at 
mammalian promoters. Genome Research 22:2399–2408. doi: 10.1101/gr.138776.112.
Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, 
Fitzgerald S, Gil L, García-Girón C, Gordon L, Hourlier T, Hunt S, Juettemann T, Kähäri AK, Keenan S, 
Komorowska M, Kulesha E, Longden I, Maurel T, McLaren WM, Muffato M, Nag R, Overduin B, Pignatelli M, 
Pritchard B, Pritchard E, Riat HS, Ritchie GR, Ruffier M, Schuster M, Sheppard D, Sobral D, Taylor K, Thormann A, 
Trevanion S, White S, Wilder SP, Aken BL, Birney E, Cunningham F, Dunham I, Harrow J, Herrero J, Hubbard TJ, 
Johnson N, Kinsella R, Parker A, Spudich G, Yates A, Zadissa A, Searle SM. 2013. Ensembl 2013. Nucleic Acids 
Research 41:D48–D55. doi: 10.1093/nar/gks1236.
Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, Cabili MN, 
Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, Regev A, Rinn JL, Lander ES. 2009. Chromatin 
signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458:223–227. 
doi: 10.1038/nature07672.
Heidemann M, Hintermair C, Voß K, Eick D. 2012. Dynamic phosphorylation patterns of RNA polymerase II CTD 
during transcription. Biochimica et Biophysica Acta 1829:55–62. doi: 10.1016/j.bbagrm.2012.08.013.
Hintermair C, Heidemann M, Koch F, Descostes N, Gut M, Gut I, Fenouil R, Ferrier P, Flatley A, Kremmer E, 
Chapman RD, Andrau JC, Eick D. 2012. Threonine-4 of mammalian RNA polymerase II CTD is targeted  
by Polo-like kinase 3 and required for transcriptional elongation. The EMBO Journal 31:2784–2797.  
doi: 10.1038/emboj.2012.123.
Hsin JP, Li W, Hoque M, Tian B, Manley JL. 2014. RNAP II CTD tyrosine 1 performs multiple functions in vertebrate 
cells. eLife 3:e02112. doi: 10.7554/eLife.02112.
Hsin JP, Sheth A, Manley JL. 2011. RNAP II CTD phosphorylated on threonine-4 is required for histone mRNA 3' 
end processing. Science 334:683–686. doi: 10.1126/science.1206034.
Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, 
Kuersten S, Markenscoff-Papadimitriou E, Kuhl D, Bito H, Worley PF, Kreiman G, Greenberg ME. 2010. 
Widespread transcription at neuronal activity-regulated enhancers. Nature 465:182–187. doi: 10.1038/
nature09033.
Koch F, Fenouil R, Gut M, Cauchy P, Albert TK, Zacarias-Cabeza J, Spicuglia S, de la Chapelle AL, Heidemann M, 
Hintermair C, Eick D, Gut I, Ferrier P, Andrau JC. 2011. Transcription initiation platforms and GTF recruitment 
at tissue-specific enhancers and promoters. Nature Structural & Molecular Biology 18:956–963. doi: 10.1038/
nsmb.2085.
Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA 
sequences to the human genome. Genome Biology 10:R25. doi: 10.1186/gb-2009-10-3-r25.
Li G, Ruan X, Auerbach RK, Sandhu KS, Zheng M, Wang P, Poh HM, Goh Y, Lim J, Zhang J, Sim HS, Peh SQ, 
Mulawadi FH, Ong CT, Orlov YL, Hong S, Zhang Z, Landt S, Raha D, Euskirchen G, Wei CL, Ge W, Wang H, 
Davis C, Fisher-Aylor KI, Mortazavi A, Gerstein M, Gingeras T, Wold B, Sun Y, Fullwood MJ, Cheung E, Liu E, 
Sung WK, Snyder M, Ruan Y. 2012. Extensive promoter-centered chromatin interactions provide a topological 
basis for transcription regulation. Cell 148:84–98. doi: 10.1016/j.cell.2011.12.014.
Mayer A, Heidemann M, Lidschreiber M, Schreieck A, Sun M, Hintermair C, Kremmer E, Eick D, Cramer P. 2012. 
CTD tyrosine phosphorylation impairs termination factor recruitment to RNA polymerase II. Science 336:1723–1725. 
doi: 10.1126/science.1219651.
Natoli G, Andrau JC. 2012. Noncoding transcription at enhancers: general principles and functional models. 
Annual Review of Genetics 46:1–19. doi: 10.1146/annurev-genet-110711-155459.
Genes and chromosomes | Genomics and evolutionary biology
Descostes et al. eLife 2014;3:e02105. DOI: 10.7554/eLife.02105 19 of 19
Short report
Pekowska A, Benoukraf T, Zacarias-Cabeza J, Belhocine M, Koch F, Holota H, Imbert J, Andrau JC, Ferrier P, 
Spicuglia S. 2011. H3K4 tri-methylation provides an epigenetic signature of active enhancers. The EMBO 
Journal 30:4198–4210. doi: 10.1038/emboj.2011.295.
Preker P, Nielsen J, Kammler S, Lykke-Andersen S, Christensen MS, Mapendano CK, Schierup MH, Jensen TH. 
2008. RNA exosome depletion reveals transcription upstream of active human promoters. Science 322:1851–1854. 
doi: 10.1126/science.1164096.
Saldanha AJ. 2004. Java Treeview–extensible visualization of microarray data. Bioinformatics 20:3246–3248. 
doi: 10.1093/bioinformatics/bth349.
Seila AC, Calabrese JM, Levine SS, Yeo GW, Rahl PB, Flynn RA, Young RA, Sharp PA. 2008. Divergent transcription 
from active promoters. Science 322:1849–1851. doi: 10.1126/science.1162253.
Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, 
Walker JR, Hogenesch JB. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. 
Proceedings of the National Academy of Sciences of the United States of America 101:6062–6067. doi: 10.1073/
pnas.0400782101.
Turatsinze JV, Thomas-Chollier M, Defrance M, van Helden J. 2008. Using RSAT to scan genome sequences 
for transcription factor binding sites and cis-regulatory modules. Nature Protocols 3:1578–1588. doi: 10.1038/
nprot.2008.97.
Zhu LJ, Gazin C, Lawson ND, Pagès H, Lin SM, Lapointe DS, Green MR. 2010. ChIPpeakAnno: a Bioconductor 
package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 11:237. doi: 10.1186/1471-2105-11-237.
